Use of Low-Dose Aspirin in Primary Prevention of Cardiovascular Events Not Recommended

Now they tell us.

"The use of low-dose aspirin in the primary prevention of cardiovascular events in healthy individuals with asymptomatic atherosclerosis is currently not warranted, according to the lead researcher of a large 'real-world' study presented today at the European Society of Cardiology (ESC) 2009 Congress.

In the randomized trial of 3350 subjects deemed at high risk for cardiovascular and cerebrovascular events because of a low ankle-brachial index (ABI)..., aspirin had absolutely no effect on reducing events compared with placebo, Dr Gerry Fowkes (University of Edinburgh, Scotland) reported on behalf of the Aspirin for Asymptomatic Atherosclerosis (AAA) trialists.

However, aspirin did increase the risk of major hemorrhage.

The bleeding effect 'is a real obstacle,' Fowkes told heartwire. 'I don't think the evidence is convincing enough as yet that aspirin should be used routinely in the general population.'"

Then there is this:

"Daily aspirin therapy helps lower the risk of heart attack and stroke..."

and this:

"Evidence is rapidly growing that supports aspirin's use in lowering the rates of heart attack, stroke..."

Still think they have any idea about what is going on?

Fitness is your true friend without the caprices of Big Sick Care.

Get fit.